INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $30,000 | -46.4% | 26,504 | +5.9% | 0.00% | – |
| Q4 2021 | $56,000 | -54.1% | 25,017 | -29.9% | 0.00% | – |
| Q3 2021 | $122,000 | +19.6% | 35,706 | +4.8% | 0.00% | – |
| Q2 2021 | $102,000 | -30.6% | 34,064 | +153.0% | 0.00% | – |
| Q2 2015 | $147,000 | -27.2% | 13,465 | -15.1% | 0.00% | – |
| Q2 2014 | $202,000 | -12.9% | 15,861 | +19.2% | 0.00% | – |
| Q3 2013 | $232,000 | -10.1% | 13,305 | -16.3% | 0.00% | -100.0% |
| Q2 2013 | $258,000 | – | 15,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
| Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
| Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
| PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
| Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
| ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |